Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 2:11:623324.
doi: 10.3389/fimmu.2020.623324. eCollection 2020.

T-Bet Controls Cellularity of Intestinal Group 3 Innate Lymphoid Cells

Affiliations

T-Bet Controls Cellularity of Intestinal Group 3 Innate Lymphoid Cells

Jan-Hendrik Schroeder et al. Front Immunol. .

Abstract

Innate lymphoid cells (ILC) play a significant immunological role at mucosal surfaces such as the intestine. T-bet-expressing group 1 innate lymphoid cells (ILC1) are believed to play a substantial role in inflammatory bowel disease (IBD). However, a role of T-bet-negative ILC3 in driving colitis has also been suggested in mouse models questioning T-bet as a critical factor for IBD. We report here that T-bet deficient mice had a greater cellularity of NKp46-negative ILC3 correlating with enhanced expression of RORγt and IL-7R, but independent of signaling through STAT1 or STAT4. We observed enhanced neutrophilia in the colonic lamina propria (cLP) of these animals, however, we did not detect a greater risk of T-bet-deficient mice to develop spontaneous colitis. Furthermore, by utilizing an in vivo fate-mapping approach, we identified a population of T-bet-positive precursors in NKp46-negative ILC3s. These data suggest that T-bet controls ILC3 cellularity, but does do not drive a pathogenic role of ILC3 in mice with a conventional specific pathogen-free microbiota.

Keywords: ILCs; T-bet; innate lymphoid cells; intestinal inflammation; mucosal homeostasis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
T-bet controls cellularity of intestinal NKp46- ILC3 cLP. ILC of untreated mice were isolated for flow cytometry analysis. (A) ILC were gated as live CD45+ Lin- CD127+ leukocytes. (B) NKp46-, CCR6+ and double-negative ILC3 in C57BL/6 and C57BL/6-background Tbx21 -/- mice were analyzed as live CD45+ Lin- CD127+ RORγt+ leukocytes. (C) Cell number fold change and counts per colon of total NKp46-negative ILC3 and percentage from RORγt+ ILC and counts per colon of NKp46- CCR6- and CCR6+ ILC3 are shown. (D) NKp46-, CCR6+ and double-negative cLP ILC3 from Rag2 -/- and TRnUC mice were analyzed as live CD45+ Lin- CD127+ RORγt+ leukocytes. (E) Cell number fold change and counts per colon of total NKp46-negative ILC3 and percentage of CCR6+ and NKp46- CCR6- ILC3 from RORγt+ ILC are shown. Data shown are representative of a minimum of 7 (B, C) or 4 (D, E) biological replicates.
Figure 2
Figure 2
NKp46- ILC3 have fate mapper expression of T-bet. Intestinal lamina propria ILC were isolated for flow cytometry analysis. (A) See method section for further details on the design. (B) T-betFM and T-bet expression in live CD45+ Lin- CD127+ NKp46+ NK1.1+ cLP ILC and (C) T-betFM expression in live CD45+ Lin- CD127+ NKp46+ and NKp46- SI LP ILC3 are illustrated. Data shown are representative of one experiment (B) or 2 (C) replicates.
Figure 3
Figure 3
T-bet deficiency promotes intestinal neutrophilia. Leukocytes were isolated from the colonic lamina propria of untreated WT and Tbx21 -/- mice for flow cytometry analysis. (A, B) IL-17A and IFNγ expression in live CD45+ Lin- CD127+ CD90.2+ leukocytes after a 4 h stimulation with PMA and ionomycin was analyzed and statistical analyses are shown. (C, D) CD11b+ Gr1+ Ly6C+ F4/80- neutrophils were analyzed from a live CD45+ cLP leukocyte population and neutrophil counts per colon are shown. (E) CD11b geometric median fluorescence intensity (gMFI) and granularity (SSC-A gMFI) were determined for WT and Tbx21 -/- cLP neutrophils. (F–I) Tbx21 -/- mice received a fecal transplant with pathogenic microbes derived from TRUC mice (31). (F) Changes in body weights were monitored on a weekly basis in Tbx21 -/- mice upon FMT and Tbx21 -/- control mice. Colon and spleen mass (G) and cLP neutrophil cellularity (H) were determined 3 weeks upon FMT treatment. (I) CD11b gMFI and SSC-A gMFI in cLP neutrophils 3 weeks upon FMT treatment are illustrated. Data shown are representative of 3 biological replicates.
Figure 4
Figure 4
T-bet deficiency promotes RORγt and CD127 expression by cLP ILC3. ILC were isolated from the colonic lamina propria of C57BL/6 and C57BL/6-background Tbx21 -/-, and BALB/c-background Rag2 -/- and TRnUC mice for flow cytometry analysis of RORγt and CD127 expression. RORγt gMFI expression in total NKp46-, CCR6+ and double-negative ILC3 from (A) WT and Tbx21 -/- and (B) Rag2 -/- and TRnUC mice was analyzed within the live CD45+ Lin- CD127+ RORγt+ leukocyte population. (C) CD127 surface expression in total NKp46-negative ILC3 and ILC2 defined as KLRG1+ ICOS+ CD127+ ILC is illustrated with flow cytometry histograms. Statistical analyses of CD127 surface expression (gMFI) on total NKp46-, CCR6+ and double-negative ILC3 and ILC2 from (D) WT and Tbx21 -/- and (E) Rag2 -/- mice are presented. Data shown are representative of a minimum of 7 (A–D) or 4 (E) biological replicates.
Figure 5
Figure 5
STAT1 and STAT4 deficiency does not promote ILC3 cellularity. cLP ILC were isolated from mice for flow cytometry analysis. Counts per colons of (A) NKp46-CCR6- and CCR6+ ILC3 and (B) ILC2 in WT, Stat1-/- and Stat4 -/- mice are shown. Data shown are representative of 4 biological replicates.

Similar articles

Cited by

References

    1. Bal SM, Golebski K, Spits H. Plasticity of innate lymphoid cell subsets. Nat Rev Immunol (2020) 20(9):552–65. 10.1038/s41577-020-0282-9 - DOI - PubMed
    1. Klose CS, Kiss EA, Schwierzeck V, Ebert K, Hoyler T, d’Hargues Y, et al. A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells. Nature (2013) 494(7436):261–5. 10.1038/nature11813 - DOI - PubMed
    1. Ishizuka IE, Constantinides MG, Gudjonson H, Bendelac A. The Innate Lymphoid Cell Precursor. Annu Rev Immunol (2016) 34:299–316. 10.1146/annurev-immunol-041015-055549 - DOI - PubMed
    1. Soderquest K, Hertweck A, Giambartolomei C, Henderson S, Mohamed R, Goldberg R, et al. Genetic variants alter T-bet binding and gene expression in mucosal inflammatory disease. PloS Genet (2017) 13(2):e1006587. 10.1371/journal.pgen.1006587 - DOI - PMC - PubMed
    1. Ito R, Shin-Ya M, Kishida T, Urano A, Takada R, Sakagami J, et al. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin Exp Immunol (2006) 146(2):330–8. 10.1111/j.1365-2249.2006.03214.x - DOI - PMC - PubMed

Publication types

MeSH terms

Substances